Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression.

A recent study reveals that resveratrol, a compound present in red wine, may hold the key to effectively treating depression and anxiety without the need for drugs.

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

From “BUT-MAN” to “HWKTUA,” nearly 400 applications were rejected in 2024. Scroll through the full list of custom plates the ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to Johnson & Johnson.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...